Kyung Nam Pharm Co Ltd (053950) — Cash Flow Reinvestment Rate
Kyung Nam Pharm Co Ltd (053950) has a Cash Flow Reinvestment Rate of 413.65x as of June 2026, reinvesting ₩33.69 Billion (capex ₩3.83 Billion plus investments ₩29.86 Billion) from operating cash flow of ₩81.44 Million. See 053950 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kyung Nam Pharm Co Ltd Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Kyung Nam Pharm Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see Kyung Nam Pharm Co Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Kyung Nam Pharm Co Ltd (2007–2024)
Year-by-year capital reinvestment analysis for Kyung Nam Pharm Co Ltd. See financial agility of Kyung Nam Pharm Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.10x | ₩3.85 Billion | ₩1.84 Billion | ₩1.67 Billion | ▼ -88.3% |
| 2023 | 17.89x | ₩12.40 Billion | ₩693.30 Million | ₩4.18 Billion | ▼ -62.5% |
| 2022 | 47.75x | ₩3.42 Billion | ₩71.58 Million | ₩2.92 Billion | ▲ +153.1% |
| 2020 | 18.86x | ₩49.33 Billion | ₩2.62 Billion | ₩45.58 Billion | ▲ +2969.4% |
| 2017 | 0.61x | ₩1.06 Billion | ₩1.72 Billion | ₩1.05 Billion | ▲ +170.9% |
| 2016 | 0.23x | ₩1.11 Billion | ₩4.89 Billion | ₩1.11 Billion | ▼ -99.0% |
| 2010 | 22.56x | ₩10.89 Billion | ₩482.65 Million | ₩10.89 Billion | ▼ -15.9% |
| 2007 | 26.83x | ₩3.99 Billion | ₩148.79 Million | ₩3.99 Billion | — |